Resistell News:

Uncovering the hidden cost of delayed antibiotic resistance results

Uncovering the hidden cost of delayed antibiotic resistance results
Resistell News:

Uncovering the hidden cost of delayed antibiotic resistance results

Antibiotic resistance changes treatable infections into significant health threats. Along with the clinical challenges comes an extra financial load, as antibiotic resistance typically adds around $1,400 to the hospital bill for treating bacterial infections, according to the CDC in the US. This steep rise indicates a concerning trend where healthcare costs climb hand-in-hand with the complexity of treating resistant strains.

More
Uncovering the hidden cost of delayed antibiotic resistance results

Latest news

Meet us it Berlin at Novel Antimicrobials and AMR Diagnostics 2019
13th March 2019

Meet us it Berlin at Novel Antimicrobials and AMR Diagnostics 2019

We invite you to meet us in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). For more details please visit https://amr-conference.com
More
Resistell wins 3rd stage of VentureKick
27th December 2018

Resistell wins 3rd stage of VentureKick

The jury of industry experts and investors selected Resistell to receive the highest level of Venture Kick’s financial support to bring their businesses to market.
More
12th December 2018

Resistell closes the seed financing round

Resistell has closed an oversubscribed seed financing round. Lead Investor Occident Group AG, Hemex AG and six other private investors invested in the EPFL spin-off developing the world’s fastest phenotypic antibiotic susceptibility test.
More
11th November 2018

Resistell a finalist of the Swiss Technology Award 2018!

Resistell AG a finalist of the Swiss Technology Award 2018!
More
Resistell wins the MassChallenge Switzerland 2018 Gold Award
1st November 2018

Resistell wins the MassChallenge Switzerland 2018 Gold Award

Resistell wins the MassChallenge Switzerland 2018 Gold Award
More